Prescription labels have a lot of details on them, which can make it difficult for patients to find and use important information.
Use of these drugs as medications, though, promising, may be restricted for various reasons to a select few.
Proactive strategies to protect health care data from hackers.
Mobile apps can help consumers acquire medications, but few help with adherence beyond automatic refills or medication synchronization.
Pharmacy personnel can be integrated to optimize antimicrobial use.
These drugs have interesting mechanisms, unique use, or may support expanded indications in the future.
Axitinib, cabozantinib, and lenvatinib are first-line treatment options.
Pharmacists can advocate for teen vaccination by providing informational sessions at local high schools as well as through social media platforms.
Specific drugs, foods, and supplements can lead to this condition.
Experts in gynecologic oncology provide insight on available patient assistance programs to help lower costs of PARP inhibitors for the treatment of ovarian cancer, and how pharmacists can aid in obtaining this information.
Mitigating the likelihood of pharmacy staff burnout requires a multifactorial approach.
Combination netupitant and palonosetron capsules/fosnetupitant and palonosetron for injection (Akynzeo) is indicated to prevent acute and delayed nausea and vomiting associated with highly emetogenic chemotherapy.
Pharmacy professionals can bring in the right people at the right time to identify needed changes and develop an action plan.
Finding ways to eliminate barriers to care helps narrow the gap.
In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.
Establishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.
Immunotherapies will continue to change standards of care for treatment of RCC.
Prior authorizations have delayed time to treatment for patients and can directly impact clinical outcomes.
Protecting this vulnerable patient population requires specially designed strategies.
Pharmacists must remain nimble to help patients continue receiving the medications they need, as technology now plays a central role in workflow and medication management.
Clinical pharmacy services became eligible for reimbursement by all health insurance in Germany; however, challenges persist in upscaling and sustaining these services.
Sixty years after the first hormonal birth control pill was marketed to women, men still have limited options with variable efficacy for birth control.
The mainstay of treatment for schizophrenia and schizoaffective disorder includes antipsychotics.
The implementation of genetic testing for patients prescribed medications associated with progressive multifocal leukoencephalopathy is likely to improve safety outcomes.
HER2-mutant NSCLC is associated with poor prognosis. Zongertinib and BAY 2927088 are HER2 tyrosine kinase inhibitors that have activity in NSCLC with manageable toxicity profiles.
Idiopathic intracranial hypertension was previously considered a rare condition, however, its prevalence is increasing in parallel with obesity in patient populations.
Pharmacists who educate patients with multiple sclerosis and expand their understanding and knowledge of the condition empowers them to take part in a more active role in managing their health.
Being able to communicate in a different language can improve treatment adherence and medication efficacy outcomes
The adjuvant therapy has demonstrated varied efficacy for patients.